European equities traded in the US as American depositary receipts were tracking lower late Wednesday morning, declining 0.75% to 1,470.43 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by Grifols (GRFS) and argenx (ARGX), which rose 4.2% and 2.5% respectively. They were followed by internet advertising firm Criteo (CRTO), which was up 2%.
The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical firm Cellectis (CLLS), which tumbled 15% and 7.1% respectively. They were followed by biopharmaceutical firm DBV Technologies (DBVT) and internet browser firm Opera (OPRA), which were down 4.5% and 1.2% respectively.
From the UK and Ireland, the gainers were led by Trinity Biotech (TRIB) and Bicycle Therapeutics (BCYC), which advanced 2.8% and 2.7% respectively. They were followed by Adaptimmune Therapeutics (ADAP) and Autolus Therapeutics (AUTL), which increased 2.2% and 1.8% respectively.
The decliners from the UK and Ireland were led by Biodexa Pharmaceuticals (BDRX) and Silence Therapeutics (SLN), which lost 7.6% and 1.4% respectively. They were followed by insurance firm Prudential (PUK) and communications company WPP (WPP), which were off 0.9% and 0.7% respectively.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.